KNSA: Kiniksa Pharmaceuticals Ltd - Class A
今日KNSA汇率已更改-4.17%。当日,交易品种以低点78.74和高点84.06进行交易。
关注Kiniksa Pharmaceuticals Ltd - Class A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KNSA新闻
- Stock Market Today: Nasdaq Jumps As Tesla, Meta Earnings Loom; Medical Stock Pops (Live Coverage)
- Hasbro Races Past Go As Profits Soar, Leads 10 To Best Stock Lists
- Dow Jones Futures Rise, AI Stocks Jump On SpaceX Earnings, Supermicro Sales; Tesla, Meta On Deck
- Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight
- Retailer ELF Steals Headlines From AI Giants. ELF Among 11 Hot Prospects New To Best Stock Lists
- Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment (NASDAQ:KNSA)
- Bloom Energy Soars Nearly 11%. It's Among 18 High Performers Joining Best Stock Lists.
- AI Flash Memory Maker Everpure Among 16 Growth Names On IBD Best Stock Lists
- Taiwan Semiconductor Leads This Group On 17 Onto Best Stock Screens
- AI Stock NetApp Hits Early Buy Trigger After Big Support At A Key Level
- AI Leader AMD Breaks Out Past New Buy Point With This Bullish Signal
- Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why
- Stock Market Today: Nasdaq Charges Higher As AI Leaders Mount A Rally; Salesforce Extends Losses (Live Coverage)
- Mexico-Based Energy Leader Vista Eyes Buy Point As Oil Prices Surge On Middle East Conflict
- Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat
- TGTX Stock Outperforms 95% of Stocks. Here's Why.
- Three Biotech Stocks Stick Out With Their Stellar Charts
- Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan
- KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook
- Kiniksa Pharmaceuticals International, plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KNSA) 2026-07-31
- Stock Market Rises Amid Apple, Amazon, Meta, Microsoft Earnings, Soaring Yields: Weekly Review
- MDGL Stock Down Despite Q2 Beat, MASH Drug Drives Top-Line Y/Y Growth
- Teva Q2 Earnings Lag Estimates, 2026 Revenue View Raised, Stock Rises
- Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?
常见问题解答
KNSA股票今天的价格是多少?
Kiniksa Pharmaceuticals Ltd - Class A股票今天的定价为79.70。它在78.74 - 84.06范围内交易,昨天的收盘价为83.17,交易量达到1937。KNSA的实时价格图表显示了这些更新。
Kiniksa Pharmaceuticals Ltd - Class A股票是否支付股息?
Kiniksa Pharmaceuticals Ltd - Class A目前的价值为79.70。股息政策取决于公司,而投资者也会关注115.29%和USD。实时查看图表以跟踪KNSA走势。
如何购买KNSA股票?
您可以以79.70的当前价格购买Kiniksa Pharmaceuticals Ltd - Class A股票。订单通常设置在79.70或80.00附近,而1937和-5.19%显示市场活动。立即关注KNSA的实时图表更新。
如何投资KNSA股票?
投资Kiniksa Pharmaceuticals Ltd - Class A需要考虑年度范围36.56 - 84.06和当前价格79.70。许多人在以79.70或80.00下订单之前,会比较7.89%和。实时查看KNSA价格图表,了解每日变化。
Kiniksa Pharmaceuticals Ltd - Class A股票的最高价格是多少?
在过去一年中,Kiniksa Pharmaceuticals Ltd - Class A的最高价格是84.06。在36.56 - 84.06内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Kiniksa Pharmaceuticals Ltd - Class A的绩效。
Kiniksa Pharmaceuticals Ltd - Class A股票的最低价格是多少?
Kiniksa Pharmaceuticals Ltd - Class A(KNSA)的最低价格为36.56。将其与当前的79.70和36.56 - 84.06进行比较,可以发现潜在的长期切入点。观看KNSA在图表上的实时走势以获取更多详细信息。
KNSA股票是什么时候拆分的?
Kiniksa Pharmaceuticals Ltd - Class A历史上曾经历过股票拆分。这些变化在公司行动后的、83.17和115.29%中可见。
- 前一天收盘价
- 83.17
- 开盘价
- 84.06
- 卖价
- 79.70
- 买价
- 80.00
- 最低价
- 78.74
- 最高价
- 84.06
- 交易量
- 1.937 K
- 日变化
- -4.17%
- 月变化
- 7.89%
- 6个月变化
- 48.20%
- 年变化
- 115.29%
- 实际值
- 预测值
- 198 K
- 前值
- 199 K
- 实际值
- 预测值
- 1.723 M
- 前值
- 1.710 M
- 实际值
- 预测值
- 0.0%
- 前值
- -0.1%
- 实际值
- 预测值
- 前值
- 1.955%